+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neuromodulation Market - Global Forecast 2026-2032- Product Image
Neuromodulation Market - Global Forecast 2026-2032- Product Image
New

Neuromodulation Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968620
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The neuromodulation market is advancing quickly amid new clinical uses, evolving healthcare integration, and shifting commercial priorities. Senior decision-makers must carefully evaluate the sector's complexities, as market forces call for both operational agility and strong strategic vision.

Market Snapshot: Neuromodulation Market Size and Growth Trends

The global neuromodulation market grew from USD 6.61 billion in 2025 to USD 7.06 billion in 2026 and is expected to reach USD 10.65 billion by 2032, demonstrating a compound annual growth rate (CAGR) of 7.04%. This upward trend highlights expanding adoption as decision-makers identify opportunities in the face of changing clinical applications and regulatory frameworks. Growth is driven by the need for advanced neuromodulation solutions, escalating neurological case volumes, and increased emphasis on product innovation and adaptability.

Scope & Segmentation

This report delivers a highly detailed segmentation to help senior leaders identify new growth opportunities and tailor their market entry or expansion strategies. The comprehensive scope covers a spectrum of devices, medical conditions, care settings, technology approaches, and region-specific considerations:

  • Product Types: Deep Brain Stimulation with directional and ring leads; Sacral Nerve Stimulation with both rechargeable and nonrechargeable systems; Spinal Cord Stimulation available in closed-loop and open-loop models; Transcutaneous Electrical Nerve Stimulation provided in portable or stationary variants; Vagus Nerve Stimulation as both implanted and noninvasive options.
  • Clinical Applications: Solutions address chronic pain, depression, epilepsy, movement disorders, and urinary incontinence, along with evolving uses in broader neuropsychiatric settings.
  • End-User Settings: Deployments span ambulatory surgical centers, hospitals, outpatient clinics, home care, and tertiary referral centers, reflecting the expansion of treatment beyond traditional clinical sites.
  • Technology Modalities: Both invasive and noninvasive systems each carry their own regulatory and reimbursement pathways, affecting clinical adoption rates and shaping commercialization strategies.
  • Regions: Americas, Europe Middle East & Africa, and Asia-Pacific, each demanding a tailored approach due to differing regulatory landscapes, commercialization schedules, and partnership ecosystems.

Key Takeaways for Strategic Decision-Makers

  • Device advances in electrode design and adaptive stimulation promote greater precision, broadening therapeutic options and enabling differentiated positioning.
  • Healthcare delivery is shifting, with outpatient and home-based neuromodulation care rising due to advances in remote monitoring and minimally invasive procedures.
  • Payer scrutiny has intensified, demanding robust evidence of both clinical efficacy and cost-effectiveness, which shapes manufacturers' priorities for real-world data and stakeholder engagement.
  • Commercial strategies hinge on balancing clinical results, operational practicality, and alignment with payer requirements to promote long-term sustainability.
  • Supply chains must be adaptable, relying on proactive sourcing, quick onboarding, and regional service localization to reduce operational disruptions and ensure steady delivery.
  • Competitive strengths are emerging where hardware design meets integrated service delivery, as seen in remote programming, enhanced analytics, and performance-based contracts.

Tariff Impact: Supply Chain and Procurement Strategies

Recent adjustments to United States tariff policies have increased supply chain complexity for neuromodulation device manufacturers and procurement teams. To minimize disruption, organizations are adopting several key tactics:

  • Expanding supplier networks and accelerating onboarding of alternative partners to ensure business continuity.
  • Including tariff-abatement clauses in contracts to introduce financial flexibility and quick cost adjustments into existing agreements.
  • Enhancing collaboration between compliance and manufacturing units to maintain regulatory standards during supplier transitions.
  • Positioning device support, service, and repair closer to care sites to limit tariff impacts and maximize operational uptime.

Through these steps, supply chain management is evolving into a core element of strategic planning, not just an operational function.

Methodology & Data Sources

The report leverages a triangulated method, combining interviews with clinical and procurement stakeholders, a thorough review of relevant literature and regulations, and scenario analysis. Technology evaluation and mapping along the value chain further ensure relevance and reliability for decision-makers.

Neuromodulation Market: Why This Report Matters

  • Supports executives in benchmarking operational and clinical approaches against sector developments and responding proactively to ongoing changes.
  • Guides targeted investment in products, technologies, and priority regions to enhance market positioning and returns.
  • Provides supply chain and procurement teams with actionable intelligence for regulatory adaptation and risk mitigation in evolving policy environments.

Conclusion

The neuromodulation market is entering a period of complex alignment, adaptive evidence, and strengthened operational resilience. Synchronizing technology integration with business goals will help leaders set new clinical standards and secure sustained market growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Neuromodulation Market, by Application
8.1. Chronic Pain Management
8.2. Depression
8.3. Epilepsy
8.4. Movement Disorders
8.5. Urinary Incontinence
9. Neuromodulation Market, by End User
9.1. Ambulatory Surgical Centers
9.2. Home Care
9.3. Hospitals
10. Neuromodulation Market, by Product Type
10.1. Deep Brain Stimulation
10.1.1. Directional
10.1.2. Ring
10.2. Sacral Nerve Stimulation
10.2.1. Nonrechargeable
10.2.2. Rechargeable
10.3. Spinal Cord Stimulation
10.3.1. Closed Loop
10.3.2. Open Loop
10.4. Transcutaneous Electrical Nerve Stimulation
10.4.1. Portable
10.4.2. Stationary
10.5. Vagus Nerve Stimulation
10.5.1. Implanted
10.5.2. Noninvasive
11. Neuromodulation Market, by Technology
11.1. Invasive
11.2. Noninvasive
12. Neuromodulation Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Neuromodulation Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Neuromodulation Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Neuromodulation Market
16. China Neuromodulation Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Axonics Modulation Technologies, Inc.
17.7. Boston Scientific Corporation
17.8. ElectroCore, Inc.
17.9. Helius Medical Technologies, Inc.
17.10. LivaNova PLC
17.11. Medtronic plc
17.12. MicroTransponder, Inc.
17.13. Neuronetics, Inc.
17.14. Nevro Corporation
17.15. Nuvectra Corporation
17.16. Zynex Medical, Inc.
List of Figures
FIGURE 1. GLOBAL NEUROMODULATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NEUROMODULATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NEUROMODULATION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NEUROMODULATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEUROMODULATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NEUROMODULATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEUROMODULATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES NEUROMODULATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA NEUROMODULATION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NEUROMODULATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NEUROMODULATION MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NEUROMODULATION MARKET SIZE, BY DEPRESSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NEUROMODULATION MARKET SIZE, BY DEPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NEUROMODULATION MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NEUROMODULATION MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NEUROMODULATION MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NEUROMODULATION MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NEUROMODULATION MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NEUROMODULATION MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NEUROMODULATION MARKET SIZE, BY URINARY INCONTINENCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NEUROMODULATION MARKET SIZE, BY URINARY INCONTINENCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NEUROMODULATION MARKET SIZE, BY URINARY INCONTINENCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NEUROMODULATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NEUROMODULATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NEUROMODULATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NEUROMODULATION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NEUROMODULATION MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NEUROMODULATION MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NEUROMODULATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NEUROMODULATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NEUROMODULATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NEUROMODULATION MARKET SIZE, BY DIRECTIONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NEUROMODULATION MARKET SIZE, BY DIRECTIONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NEUROMODULATION MARKET SIZE, BY DIRECTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NEUROMODULATION MARKET SIZE, BY RING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NEUROMODULATION MARKET SIZE, BY RING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NEUROMODULATION MARKET SIZE, BY RING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NEUROMODULATION MARKET SIZE, BY NONRECHARGEABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NEUROMODULATION MARKET SIZE, BY NONRECHARGEABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NEUROMODULATION MARKET SIZE, BY NONRECHARGEABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NEUROMODULATION MARKET SIZE, BY RECHARGEABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NEUROMODULATION MARKET SIZE, BY RECHARGEABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NEUROMODULATION MARKET SIZE, BY RECHARGEABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NEUROMODULATION MARKET SIZE, BY CLOSED LOOP, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NEUROMODULATION MARKET SIZE, BY CLOSED LOOP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NEUROMODULATION MARKET SIZE, BY CLOSED LOOP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NEUROMODULATION MARKET SIZE, BY OPEN LOOP, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NEUROMODULATION MARKET SIZE, BY OPEN LOOP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NEUROMODULATION MARKET SIZE, BY OPEN LOOP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NEUROMODULATION MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NEUROMODULATION MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NEUROMODULATION MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NEUROMODULATION MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NEUROMODULATION MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NEUROMODULATION MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NEUROMODULATION MARKET SIZE, BY IMPLANTED, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NEUROMODULATION MARKET SIZE, BY IMPLANTED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NEUROMODULATION MARKET SIZE, BY IMPLANTED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NEUROMODULATION MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL NEUROMODULATION MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NEUROMODULATION MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NEUROMODULATION MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NEUROMODULATION MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NEUROMODULATION MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NEUROMODULATION MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL NEUROMODULATION MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NEUROMODULATION MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NEUROMODULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS NEUROMODULATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. EUROPE NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. EUROPE NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. EUROPE NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. EUROPE NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. EUROPE NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 132. EUROPE NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 134. EUROPE NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 135. EUROPE NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 136. EUROPE NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 147. AFRICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. AFRICA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. AFRICA NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. AFRICA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. AFRICA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 152. AFRICA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 153. AFRICA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 154. AFRICA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 155. AFRICA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 156. AFRICA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL NEUROMODULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. ASEAN NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. ASEAN NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. ASEAN NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. ASEAN NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. ASEAN NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 173. ASEAN NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 174. ASEAN NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 175. ASEAN NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 176. ASEAN NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 177. ASEAN NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. GCC NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. GCC NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. GCC NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. GCC NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. GCC NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 183. GCC NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 184. GCC NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 185. GCC NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 186. GCC NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 187. GCC NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. BRICS NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. BRICS NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 200. BRICS NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. BRICS NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 202. BRICS NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 203. BRICS NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 204. BRICS NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 205. BRICS NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 206. BRICS NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 207. BRICS NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 208. G7 NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. G7 NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. G7 NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. G7 NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. G7 NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 213. G7 NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 214. G7 NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 215. G7 NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 216. G7 NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 217. G7 NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 218. NATO NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. NATO NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. NATO NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. NATO NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 222. NATO NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 223. NATO NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 224. NATO NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 225. NATO NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 226. NATO NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 227. NATO NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES NEUROMODULATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 239. CHINA NEUROMODULATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 240. CHINA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. CHINA NEUROMODULATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. CHINA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 243. CHINA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 244. CHINA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 245. CHINA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2032 (USD MILLION)
TABLE 246. CHINA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 247. CHINA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2032 (USD MILLION)
TABLE 248. CHINA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Neuromodulation market report include:
  • Abbott Laboratories
  • Axonics Modulation Technologies, Inc.
  • Boston Scientific Corporation
  • ElectroCore, Inc.
  • Helius Medical Technologies, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MicroTransponder, Inc.
  • Neuronetics, Inc.
  • Nevro Corporation
  • Nuvectra Corporation
  • Zynex Medical, Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.06 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.65 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Neuromodulation Devices Market - Global Forecast 2026-2032 - Product Image

Neuromodulation Devices Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Neuromodulation Market by Technology, Stimulation Type, Application, End User, and Region - Global Forecast to 2030 - Product Image

Neuromodulation Market by Technology, Stimulation Type, Application, End User, and Region - Global Forecast to 2030

  • Report
  • 367 Pages
  • Global
From
Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Neuromodulation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Neuromodulation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2025-2033 - Product Image

Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From

About the Neuromodulation Device Market

Neuromodulation devices are medical devices used to treat neurological disorders and chronic pain. These devices are used in a variety of surgical procedures, such as deep brain stimulation, spinal cord stimulation, and sacral nerve stimulation. Neuromodulation devices are designed to deliver electrical stimulation to the nervous system, which can help reduce pain, improve movement, and restore normal functioning. Neuromodulation devices are used in a variety of surgical procedures, including neurosurgery, orthopedic surgery, and plastic surgery. In neurosurgery, neuromodulation devices are used to treat conditions such as Parkinson's disease, epilepsy, and chronic pain. In orthopedic surgery, neuromodulation devices are used to treat conditions such as spinal cord injuries, chronic pain, and muscle spasms. In plastic surgery, neuromodulation devices are used to treat conditions such as facial paralysis and facial nerve damage. Some of the companies in the neuromodulation device market include Medtronic, Boston Scientific, St. Jude Medical, Abbott, and Cyberonics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.